Catherine Novack
Stock Analyst at Jones Trading
(0.27)
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
FEMY Femasys | Maintains: Buy | 10 6 | 0.89 | 574.16% | 2 | May 13, 2025 | |
RGLS Regulus Therapeutics | Downgrades: Hold | 8 7 | 8.16 | -14.22% | 2 | Apr 30, 2025 | |
RLYB Rallybio | Downgrades: Hold | n/a | n/a | n/a | 1 | Apr 15, 2025 | |
PVLA Palvella Therapeutic... | Initiates Coverage On: Buy | 45 | 21.94 | 105.1% | 1 | Mar 25, 2025 | |
PRQR ProQR Therapeutics | Initiates Coverage On: Buy | 11 | 2.02 | 444.55% | 1 | Feb 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 130 | 12.68 | 925.24% | 1 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 40 | 9.16 | 336.68% | 1 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Nov 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Oct 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 12 16 | 6.86 | 133.24% | 2 | Sep 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 14 | 2.98 | 369.8% | 1 | Sep 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 5 13 | 2.67 | 386.89% | 2 | Aug 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 4.26 | 134.74% | 1 | Apr 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 22 | 1.62 | 1258.02% | 1 | Feb 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Oct 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 160 | n/a | n/a | 1 | Jul 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 11 | n/a | n/a | 1 | Mar 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 25 | n/a | n/a | 1 | Dec 2, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 45 | n/a | n/a | 1 | Oct 4, 2021 |